(19)
(11) EP 2 014 310 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
26.12.2012 Bulletin 2012/52

(45) Mention of the grant of the patent:
24.10.2012 Bulletin 2012/43

(21) Application number: 08008365.2

(22) Date of filing: 03.03.2003
(51) International Patent Classification (IPC): 
A61K 49/22(2006.01)
C07K 14/00(2006.01)
C07K 14/71(2006.01)
 C07K 7/08(2006.01)
C07K 14/52(2006.01)

(54)

KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy

KDR- und VEGF/KDR-bindende Peptide sowie ihre Verwendung bei der Diagnose und Therapie

Peptides de liaison KDR et VEGF/KDR et leur utilisation pour le diagnostic et la thérapie

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

(30) Priority: 01.03.2002 US 360851 P
15.01.2003 US 440411 P

(43) Date of publication of application:
14.01.2009 Bulletin 2009/03

(60) Divisional application:
10185498.2 / 2301587

(62) Application number of the earlier application in accordance with Art. 76 EPC:
03711418.8 / 1572724

(73) Proprietors:
  • Dyax Corp.
    Cambridge, MA 02139 (US)
  • Bracco Suisse SA
    6928 Manno (CH)

(72) Inventors:
  • Sato, Aaron K.
    Richmond, CA 94805 (US)
  • Sexton, Daniel J.
    Somerville, MA 02144 (US)
  • Ladner, Robert C.
    Ijamsville, MD 21754 (US)
  • Dransfield, Daniel T.
    Hanson, MA 02341 (US)
  • Swenson, Rolf E.
    Princeton, NJ 08540 (US)
  • Marinelli, Edmund R.
    Lawrenceville, NJ 08648 (US)
  • Ramalingam, Kondareddiar
    Dayton, NJ 08810 (US)
  • Nunn, Adrian D.
    Lambertville, NJ 08530 (US)
  • Von Wronski, Mathew A.
    Moorestown, NJ 08057 (US)
  • Shrivastava, Ajay
    Plainsboro, NJ 08536 (US)
  • Pochon, Sibylle
    1256 Troinex (CH)
  • Bussat, Philippe
    74160 Feigères (FR)
  • Arbogast, Christophe
    74250 Viez-en-Sallaz (FR)
  • Pillai, Radhakrishna
    Cranbury, NJ 08512 (US)
  • Fan, Hong
    Plainsboro, NJ 08536 (US)
  • Linder, Karen E.
    Kingston, NJ 08528 (US)
  • Song, Bo
    Princeton, NJ 08540 (US)
  • Nanjappan, Palaniappa
    Dayton, NJ 08810 (US)
  • Yan, Feng
    Grand-Lancy (CH)

(74) Representative: Krauss, Jan 
Boehmert & Boehmert Pettenkoferstrasse 20-22
80336 München
80336 München (DE)


(56) References cited: : 
WO-A-01/52875
 WO-A-99/58162
   
  • HAIYAN JIA ET AL: "PEPTIDES ENCODED BY EXON 6 OF VEGF INHIBIT ENDOTHELIAL CELL BIOLOGICAL RESPONSES AND ANGIOGENESIS INDUCED BY VEGF" BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 283, no. 1, 2001, pages 164-173, XP002941058 ISSN: 0006-291X
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).